Work

Predictive value of LCP1 and ADPGK for immune-related adverse events across multiple cancer types in patients receiving immunotherapy-based regimens

Year: 2026

Type: article

Abstract: Immune checkpoint inhibitors (ICIs) targeting programmed cell death protein 1 (PD-1) and its ligand (PD-L1) have transformed oncology but are frequently compromised by

Source: Acta Biochimica et Biophysica Sinica

DOI: 10.3724/abbs.2026016

Authors: Xi Zhang, Yaqian Li, Li Zhang, Hongyu Liu, Wei Sun, Junhua Li, Dan Xue, Fan Zhang, Yuting Bai, Jing Zhang, Xing Gou, Dongzi Pang, Xueqin Zeng, Shuqing Wei

Institutions: Shanxi Medical University, Chinese Academy of Medical Sciences & Peking Union Medical College, Shanxi Provincial Cancer Hospital, Shanghai Jiao Tong University, Renji Hospital

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: diamond

Funder: Wu Jieping Medical Foundation

Award: G5783365073

OpenAlex ID: W7127187215

FWCI:

Cites: 11

Cited by:

Related to: